Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers

Author(s): Paredes S, Girona J, Hurt-Camejo E, Vallvé JC, Olivé S, et al.

Abstract

Objective:We evaluated vitamin status in relation to inflammatory markers and lipid peroxidation measures in patients with rheumatoid arthritis (RA).

Methods:Thirty patients with RA and 30 controls were studied. Lipid profile, vitamin A, vitamin E, and inflammatory markers were analyzed in all subjects. Susceptibility to low density lipoprotein (LDL) oxidation was evaluated in both groups by measuring the kinetics of conjugated dienes induced by hemin.

Results:Patients and controls had similar lipid profiles, except with LDL cholesterol, which was lower in the patients (p < 0.05). Patients had significantly higher plasma levels of inflammatory markers with respect to controls (p < 0.01). Plasma levels of vitamin A were lower in patients, and similar levels of vitamin E were observed in both groups. Oxidative variables, measured as the different phases of conjugated diene formation, were similar in patients and controls. We found a significant inverse correlation between vitamin A, vitamin E, and secretory type II phospholipase A2 in patients. We found a positive correlation between the affinity constant of LDL binding to glycosaminoglycans (GAG), Kd-LDL, and the lag phase of LDL oxidation (p < 0.05) in patients.

Conclusion:This report supports the hypothesis that chronic inflammation affects antioxidant vitamin levels in RA. Combined with the presence of a chronic inflammatory process and high LDL affinity for GAG, this may explain the high risk of cardiovascular disease in patients with RA.

Similar Articles

Role of cytokines in rheumatoid arthritis

Author(s): Feldmann M, Brennan FM, Maini RN

The relationship between potency of oxidative stress and severity of dilated cardiomyopathy

Author(s): Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, et al.

Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients

Author(s): Blake DR, Hall ND, Treby DA, Halliwell B, Gutteridge JM

Serum antioxidants and risk of rheumatoid arthritis

Author(s): Heliövaara M, Knekt P, Aho K, Aaran RK, Alfthan G, et al.

Serum copper/zinc superoxide dismutase levels in patients with rheumatoid arthritis

Author(s): Mazzetti I, Grigolo B, Borzì RM, Meliconi R, Facchini A

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Author(s): Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al.

Higher nitric oxide levels are associated with disease activity in Egyptian rheumatoid arthritis patients

Author(s): Ali AM, Habeeb RA, El-Azizi NO, Khattab DA, Abo-Shady RA, et al.

Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis

Author(s): Kamanli A, Naziroqlu M, Aydilek N, Hacievliyagil C

The glutathione defense system in the pathogenesis of rheumatoid arthritis

Author(s): Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ

Reactive oxygen species and superoxide dismutases: role in joint diseases

Author(s): Afonso V, Champy R, Mitrovic D, Collin P, Lomri A

Serum biochemical markers in rheumatoid arthritis

Author(s): Pallinti V, Ganesan N, Anbazhagan M, Rajasekhar G

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis

Author(s): Thiele GM, Duryee MJ, Anderson DR, Klassen LW, Mohring SM, et al.

Caffeic acid phenethyl ester modulates methotrexate-induced oxidative stress in testes of rat

Author(s): Armagan A, Uzar E, Uz E, Yilmaz HR, Kutluhan S, et al.

Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis

Author(s): Cimen MY, Cimen OB, Kacmaz M, Ozturk HS, Yorgancioglu R, et al.

Induction of superoxide dismutase by molecular oxygen

Author(s): Gregory EM, Fridovich I

Overexpression of Extracellular Superoxide Dismutase Protects against Brain Injury Induced by Chronic Hypoxia

Author(s): Zaghloul N, Patel H, Codipilly C, Marambaud P, Dewey S, et al.

Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity

Author(s): Veselinovic M, Barudzic N, Vuletic M, Zivkovic V, Tomic-Lucic A, et al.

Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets

Author(s): Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, et al.

Oxidative stress in patients with rheumatoid arthritis

Author(s): García-González A, Gaxiola-Robles R, Zenteno-Savín T

[Oxidative stress biomarkers as indicator of chronic inflammatory joint diseases stage]

Author(s): Feijóo M, Túnez I, Ruiz A, Tasset I, Muñoz E, et al.

Antioxidant enzymes; possible mechanism of gold compound treatment in rheumatoid arthritis

Author(s): Kerimova AA, Atalay M, Yusifov EY, Kuprin SP, Kerimov TM

Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase

Author(s): Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, et al.

The source and significance of raised serum enzymes in rheumatoid arthritis

Author(s): Thompson PW, Houghton BJ, Clifford C, Jones DD, Whitaker KB, et al.